HH&L Acquisition Co. (HHLA)
| Market Cap | 173.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 9.34M |
| Shares Out | 16.58M |
| EPS (ttm) | 0.19 |
| PE Ratio | 54.92 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 444 |
| Open | 10.43 |
| Previous Close | 10.44 |
| Day's Range | 10.43 - 10.44 |
| 52-Week Range | 9.80 - 10.68 |
| Beta | -0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 31, 2023 |
About HHLA
HH&L Acquisition Co. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on healthcare or healthcare-related companies in Asian markets. The company was incorporated in 2020 and is based in Central, Hong Kong. [Read more]
Financial Performance
Financial StatementsNews
DiaCarta Receives Accreditation by the College of American Pathologists (CAP)
PLEASNTON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that it has received ac...
DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023
PLEASANTON, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that it will present five data posters at the American As...
DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit
PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) granted E...
DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience
DiaCarta Starts to Receive Samples for Oncuria ® Bladder Cancer Test at its CLIA Lab
DiaCarta to Become a Publicly Listed Company Through Merger with HH&L Acquisition Co.
PLEASANTON, Calif.
HH&L Acquisition Co. Announces Closing of Upsized $414 Million Initial Public Offering and Exercise of Underwriters' Over-Allotment Option in Full
HONG KONG, Feb. 9, 2021 /PRNewswire/ -- HH&L Acquisition Co. (NYSE: HHLA.U) (the "Company") today announced the closing of its initial public offering of 41,400,000 units, which includes 5,400,000 uni...